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Abstract
Background: The relationships between the expression of ID2, EBV-LMP1 and P16(INK4A) in
Chinese classical Hodgkin lymphoma are unknown and need exploring.
Methods: Samples of classical Hodgkin lymphoma from 60 Chinese patients were analyzed for the
expression of ID2, EBV-LMP1 and p16(INK4A) proteins by immunohistochemistry.
Results: ID2 protein was expressed in 83.3% of this group of classical Hodgkin lymphoma, staining
strongly in both cytoplasm and nucleus of the Hodgkin and Reed-Sternberg (HRS) cells. EBV-LMP1
and P16(INK4A) were overexpressed in 85.0% and 71.7% of Hodgkin lymphoma, respectively. EBV-
LMP1 was noted in the cytoplasm, membrane and nucleus of HRS cells; P16(INK4A) was in the
nucleus and cytoplasm. Microscopically, ID2, EBV-LMP1 and P16(INK4A) staining distinguished the
HRS cells from the complex background of lymphocytes. ID2 was positively correlated with EBV-
LMP1(P < 0.01), but P16(INK4A) was inversely related to EBV-LMP1 (P < 0.05).
Conclusion: It is suggested that ID2, EBV-LMP1 and P16(INK4A) could play an important role in
the evolution of classical Hodgkin lymphoma, and be considered as potential adjunct markers to
identify HRS cells in diagnosis.
Background
Hodgkin lymphoma comprises two distinct entities;
namely nodular lymphocyte predominant Hodgkin lym-
phoma and classical Hodgkin lymphoma. Classical
Hodgkin lymphoma is a lymphoid neoplasm composed
of monoclonal Hodgkin cells and multinucleated Reed-
Sternberg (HRS) cells residing in an infiltrate containing a
variable mixture of non-neoplastic small lymphocytes,
eosinophils, neutrophils, histiocytes, plasma cells, fibrob-
lasts and collagen fibres. [1] There are four morphological
variants of classical Hodgkin lymphoma, namely nodular
sclerosis, mixed cellularity, lymphocyte-rich and lym-
phocyte-depleted. HRS cells are currently thought to be
derived from mature B cells at the germinal stage of differ-
entiation, and are pathognomonic in Hodgkin lym-
phoma. [1] However, HRS cells may often be scanty and
difficult to identify in sections. The pathogenesis of classi-
cal Hodgkin lymphoma remains unknown.
ID proteins are key regulators in several developmental
and cellular processes. In general, aberrant ID expression
seems to favor proliferation, to inhibit differentiation,
and to facilitate tumor neoangiogenesis.[2] From early B-
cell development to mature B cells, E2A is the first one of
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the three transcription factors (E2A, EBF, and PAX5) to be
expressed, and E2A together with EBF regulates the expres-
sion of PAX5.[3,4] The inhibitor of DNA binding ID2
(inhibitor of DNA binding 2 or inhibitor of differentia-
tion, ID2), may bind and negatively regulate E2A and
PAX5[5,6] by direct interaction. ID2 expression in devel-
oping hematopoietic cells seems to repress B-cell develop-
ment and B-cell-specific gene expression and to favor
development of other lineages, [7-11] whereas in mature
B cells, ID2 is up-regulated during plasma cell differentia-
tion with concomitant loss of expression of several B-cell
genes.[12] Furthermore, the balance between ID2 and
E2A, and between ID2 and PAX5 seem to be important for
B-cell differentiation.[13,14] ID2 has been found strongly
and uniformly expressed in the HRS cells of classic Hodg-
kin Lymphoma and probably represses B-cell-specific
gene expression by inactivation of E2A (and perhaps also
PAX5). [14] Expression of two other members of the ID
(inhibitor of differentiation) family of proteins, ID1 and
ID3, was found to be induced in the presence of latent
membrane protein 1 (LMP1), the Epstein-Barr virus onco-
protein, by the activation of NF-kappaB, phosphatidyli-
nositol 3-kinase, mitogen-activated protein kinase, and c-
Jun N-terminal kinase signaling[15,16]. However, there is
to date no study on the relationship between ID2 and
EBV-LMP1 in Hodgkin lymphoma. Overexpression of
P16(INK4A)[17] has been used as a diagnostic adjunct in
premalignant and malignant humanpapilloma virus
(HPV) lesions in gynecologic pathology[17] in recent
years. Previous research [18] also suggested that EBV-
LMP1 and P16(INK4A) had a role in the carcinogenesis of
classical Hodgkin lymphoma, but there was no corre-
sponding investigation of associations between ID2, EBV-
LMP1 and p16(INK4A), which might provide further
understanding of the mechanism. Therefore, additional
studies are needed to identify whether ID2, EBV-LMP1
and P16(INK4A) have similar diagnostic value and to
explore the possible relationship between them in classi-
cal Hodgkin lymphoma. We used the ID2, EBV-LMP1 and
P16(INK4A) antibodies to investigate the possible role of
the expression of the three proteins in 60 cases of Chinese
classical Hodgkin lymphoma. It is hoped that the study
will give information on the pathogenesis of this disease.
Methods
Patients
Sixty patients (36 men, 24 women) with histologically
confirmed classical Hodgkin lymphoma were recruited
into the study. Ethical approval for this study was not
required by our institute as the experiments carried out
did not relate to patient's privacy, impairment or treat-
ment. The Hodgkin lymphomas were classified as nodular
sclerosis (n = 29), mixed cellularity (n = 11), lymphocyte-
rich (n = 16) and lymphocyte-depleted (n = 4) variants
according to the World Health Organization recommen-
dations [1].
Immunohistochemistry
A formalin-fixed, paraffin-embedded block was selected
from each patient with Hodgkin lymphoma for immuno-
histochemical study. Paraffin sections, 4 μm in thickness,
were cut, dewaxed in xylene and rehydrated in a graded
ethanol series. Then sections were immersed in 3% hydro-
gen peroxide in methanol for 10 minutes to block endog-
enous peroxidase activity and rinsed in running water.
Subsequently they were immersed in boiling 0.01 M cit-
rate buffer (pH 6.0) in a pressure cooker, which was then
sealed and brought to full pressure for 2 minutes. It was
then de-pressured and cooled under running water. The
lid was then removed, and the hot buffer was flushed out
with cold water from a running tap. The cooled sections
were washed twice in phosphate buffered saline (PBS)
before immunocytochemical staining.
The sections were then covered the primary antibodies.
These polyclonal rabbit antibody against human ID2 pro-
tein (Santa Cruz, CA, USA), mouse monoclonal antibody
to Latent membrane protein 1 of the Epstein-Barr virus
(EBV-LMP1) (CS.1–4, DAKO) and mouse monoclonal
antibody against human P16(INK4A) protein (Zymed,
South San Franciso, CA, USA), all diluted 1 in 100. After
exposure to primary antibody for 1 hour, the sections
were allowed to react with poly peroxidase-anti-mouse/
rabbit IgG for 20 minutes by the standard PV-6000 Poly-
mer Detection System (Zymed, South San Franciso, CA,
USA). The system is a non-biotin detection system, thus,
avoiding non-specific staining due to endogenous biotin.
The sections were then washed in water, counter-stained
with Mayer's haematoxylin for one minute at room tem-
perature, dehydrated, cleared and mounted.
Human cervical squamous cell carcinoma tissues were
used as a positive control for P16(INK4A), smooth muscle
cells of vessels were used as an internal positive control for
ID2 and human nasopharyngeal carcinoma was used as a
positive control for EBV-LMP1. Negative controls were
sections treated as above but with the primary antibody
replaced by 0.01 M PBS. Expression of P16(INK4A), ID2
and EBV-LMP1 was considered positive when at least 10%
of HRS cells were stained. In addition, 10 B-cell lympho-
mas, 8 T-cell lymphomas and 10 reactive lymph nodes (4
lymph nodes sampled during resection of carcinomas and
6 lymphadenitis) were used for comparison. The B-cell
lymphomas comprised 5 diffuse large B-cell lymphomas,
4 extranodal marginal zone B-cell lymphomas (MALT
lymphomas) and 1 Burkitt lymphoma. The T-cell lym-
phomas were 2 anaplastic large cell lymphomas, 2 extran-
odal NK/T-cell lymphomas of nasal type, 2BMC Cancer 2008, 8:379 http://www.biomedcentral.com/1471-2407/8/379
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angioimmunoblastic T-cell lymphomas and 2 peripheral
T-cell lymphomas, unspecified.
Statistical analysis
The correlation between expression of the proteins was
determined by counting the positive cells in at least four
medium power fields of serial sections, calculating and
presenting as means ± SD. The statistical significance of
association was assessed by Spearman's correlation coeffi-
cient test, with SPSS15.0. A value of P less than 0.05 was
accepted as statistically significant.
Results
Expressions of ID2, EBV-LMP1 and P16(INK4A) in classical 
Hodgkin lymphoma
ID2 protein was expressed positively in 83.3% (50 out of
60) of the classical Hodgkin lymphomas (Table 1). It was
strongly positive in both cytoplasm and nucleus of the
HRS cells (Figure 1A, B), and also positive in plasma cells
or lymphoplasmacytoid cells but negative or only mini-
mally positive in reactive B and T lymphocytes in the
background of Hodgkin lymphoma. It was noted that
some HRS cells did not express ID2. In normal lymphatic
tissues, ID2 expression was mainly restricted to a few GC
and interfollicular cells. Based on morphology, the ID2-
positive cells were dendritic cells and macrophages.
Fibroblasts and endotheliocytes were positive for ID2 as
Table 1: Expression of ID2, EBV-LMP1 and P16(INK4A) in 
classical Hodgkin lymphoma
Lymphoma n ID2 EBV-LMP1 P16(INK4A)
Classical HL
Nodular sclerosis 29 25 24 22
Mixed cullularity 11 10 9 7
Lymphocyte-rich 16 12 14 11
Lymphocyte-depleted 4 3 4 3
Non-HL
DLBCL 5 4 2 3
MALT 4 3 0 1
Burkitt's 1 1 1 1
ALCL 2 2 1 1
AILT 2 1 2 1
NK/T(nasal type) 2 0 2 1
Peripheral TCL 2 0 0 1
Non-lymphomatous
Tonsilla 2 2* 0 0
Lymph nodes 10 2* 0 0
HL: Hodgkin lymphoma
DLBCL: diffuse large B cell lymphoma
MALT: extranodal marginal zone B-cell lymphoma of mucosa-
associated lymphoid tissue
Burkitt's: Burkitt's lymphoma
ALCL: anaplastic large cell lymphoma
AILT: angioimmunoblastic T-cell lymphoma
*: restricted to a few GC and interfollicular cells
Expression of ID2, EBV-LMP1 and P16(INK4A) in classical  Hodgkin lymphoma Figure 1
Expression of ID2, EBV-LMP1 and P16(INK4A) in 
classical Hodgkin lymphoma. ID2 expression in HRS 
cells (A: 200×; B: 400×); EBV-LMP1 expression in HRS cells 
(C: 200×); P16(INK4A) expression in HRS cells (D: 400×).BMC Cancer 2008, 8:379 http://www.biomedcentral.com/1471-2407/8/379
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well as smooth muscle cells of blood vessels. Eight of ten
B-cell lymphomas and three of eight T-cell lymphomas
were stained positively for ID2 (Table 1).
EBV-LMP1 protein was expressed in 85.0% (51 out of 60)
of this group of classical Hodgkin lymphomas (Table 1).
EBV-LMP1 was noted in the HRS cells, highlighting them
from the complex background of lymphocytes (Figure
1C) although positive staining could also be found mini-
mally or occasionally in the surrounding lymphocytes.
Staining was mainly nuclear and infrequently cytoplas-
mic. However, some HRS cells were negative for EBV-
LMP1 staining. Three of ten B-cell lymphomas and five of
eight T-cell lymphomas, but none of the ten reactive
lymph nodes were stained positively for EBV-LMP1 (Table
1).
P16(INK4A) protein was noted in 71.7% (43 out of 60) of
the classical Hodgkin lymphomas by immunohistochem-
istry (Table 1). P16(INK4A) was overexpressed mainly in
the nuclei of Hodgkin and Reed-Sternberg (HRS) cells
(Figure 1D). Some Hodgkin cells showed some cytoplas-
mic staining of P16(INK4A) protein as well as its nuclear
staining. Mummified HRS cells were often negative for
P16(INK4A) protein. Many of the HRS cells with a very
prominent nucleolus were positive for P16(INK4A).
However, some HRS cells were negative, distinct from the
positive cells nearby. Neither B nor T lymphocytes in the
background of the lymphoma or other tissues showed
positive staining for P16(INK4A) protein, although histi-
ocytes were weakly positive. There was no P16(INK4A)
staining in the lymphocytes, plasma cells and eosinophils.
In the control tissues and reactive lymph nodes, histio-
cytic lineage cells including macrophages, Langerhans
cells, and dendritic cells were weakly positive for
P16(INK4A). In the non-Hodgkin lymphomas (B-cell and
T-cell lymphomas), P16(INK4A) protein was found in
five out of ten B-cell lymphomas and four out of eight T-
cell lymphomas, but none of lymphocytes in the reactive
lymph nodes were positive (Table 1).
The association between ID2 and EBV-LMP1 or 
P16(INK4A)
Under the microscope, ID2 was detected in most EBV-
LMP1 positive HRS cells, and there was a positive correla-
tion between the two markers (4.400 ± 2.980 vs 4.267 ±
2.842, Rho = 0.946, P = 0.0001). However, ID2 was not
correlated with P16(INK4A) in this group of Hodgkin
lymphomas (4.400 ± 2.980 vs 3.567 ± 2.557, Rho = -
0.120, P = 0.191). It was also noted that HRS cells positive
for EBV-LMP1 were negative for P16(INK4A) and vice
versa in the same field on serial sections. The inverse cor-
relation between two proteins was significant (4.267 ±
2.842 vs 3.567 ± 2.557, Rho = -0.206, P = 0.024). Among
nine EBV-LMP1 totally negative tumours, four was posi-
tive for P16(INK4A) and also four positive for ID2. Of 51
EBV-LMP1 positive cases, 12 was negative for P16(INK4A)
and 9 negative for ID2 completely.
Discussion
ID2 can inactivate E2A and perhaps PAX5, and recurrent
chromosomal gains of the ID2 gene might contribute to
the aberrant expression [19,20]. We show here that ID2 is
not detectable in normal B cells but is strongly expressed
in HRS cells of 83.3% of Chinese classical Hodgkin lym-
phoma (50/60). These findings are in agreement with
those of a previous work from Germany [14], although
our ratio is slightly lower than in that report (42/42) [14].
These results suggest a possible role for ID2 in repressing
B-cell-specific gene expression by inactivation of E2A and
PAX5 in Hodgkin lymphoma. EBV positivity rates in clas-
sical Hodgkin lymphoma vary considerably across the
world [18,21-25] likely reflecting in part different patho-
genesis. In our series, using EBV-LMP1 immunohisto-
chemistry, we noted EBV positivity in 85.0% of cases.
Other series have used in situ hybridization for EBV early
RNAs (EBER) as well as EBV-LMP1 immunostaining
which may explain some of the differences in EBV detec-
tion rates. In our study, ID2 expression was expressed in
the vast majority of classical Hodgkin lymphoma (83.3%)
so it may be a potentially useful marker for identifying the
HRS cell in classical Hodgkin lymphoma, independent of
EBV status. In this group of Hodgkin lymphomas from
China, P16(INK4A) was also overexpressed. It was found
in 71.7% of the classical Hodgkin lymphomas, again,
much higher than in the Malasian (49.2%) [18] but in
agreement with that study it was inversely correlated with
EBV-LMP1 (P  < 0.05). The phenomenon supports the
notion that the pathogenesis of Hodgkin lymphoma is
different from that of other tumors that lose P16(INK4A).
However, there may be an association with other effects of
ID2 on HRS cells such as inactivation of the anti-prolifer-
ative function of Rb, which could indirectly induce over-
expression of P16(INK4A)[26,27].
Taken together, ID2, EBV-LMP1 and P16(INK4A) were
highly expressed in HRS cells of classical Hodgkin lym-
phoma, distinguishing the HRS cells from the background
lymphocytes.
Conclusion
Our study here suggests that combined with cellular mor-
phology, the three proteins could be considered as poten-
tial adjunct markers to identify HRS cells in diagnosis of
classical Hodgkin lymphoma.
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